79
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
TRU-016 and bendamustine
TRU-016 at 20 mg/kg, weekly by IV infusion x 2 cycles, then every 14 days x 4 cycles PLUS bendamustine (70 mg/m2 by IV infusion on Days 1 and 2 of every 28-day cycle, for 6 cycles
Bendamustine
Bendamustine at 70 mg/m2 by IV infusion on Days 1 and 2 of every 28-day cycle, for 6 cycles
15 mg/kg TRU-016 and bendamustine
TRU-016 at 15 mg/kg, weekly by IV infusion x 2 cycles, then every 14 days x 4 cycles PLUS bendamustine (70 mg/m2 by IV infusion on Days 1 and 2 of every 28-day cycle, for 6 cycles
20 mg/kg TRU-016 and bendamustine
TRU-016 at 20 mg/kg, weekly by IV infusion x 2 cycles, then every 14 days x 4 cycles PLUS bendamustine (70 mg/m2 by IV infusion on Days 1 and 2 of every 28-day cycle, for 6 cycles
For additional information regarding sites for this trial call (919) 465-4648, Syracuse
For additional information regarding sites for this trial call (919) 465-4648, Durham
For additional information regarding sites for this trial call (919) 465-4648, Augusta
For additional information regarding sites for this trial call (919) 465-4648, Columbus
For additional information regarding sites for this trial call (919) 465-4648, Cleveland
For additional information regarding sites for this trial call (919) 465-4648, Chicago
For additional information regarding sites for this trial call (919) 465-4648, Denver
For additional information regarding sites for this trial call (919) 465-4648, Seattle
For additional information regarding sites for this trial call (919) 465-4648, Hackensack
For additional information regarding sites for this trial call (919) 465-4648, Vienna
For additional information regarding sites for this trial call (919) 465-4648, Bremen
For additional information regarding sites for this trial call (919) 465-4648, Cologne
For additional information regarding sites for this trial call (919) 465-4648, Frankfurt
For additional information regarding sites for this trial call (919) 465-4648, Göttingen
For additional information regarding sites for this trial call (919) 465-4648, Kiel
For additional information regarding sites for this trial call (919) 465-4648, Mainz
For additional information regarding sites for this trial call (919) 465-4648, Mutlangen
For additional information regarding sites for this trial call (919) 465-4648, Regensburg
For additional information regarding sites for this trial call (919) 465-4648, Bialystok
For additional information regarding sites for this trial call (919) 465-4648, Gdansk
For additional information regarding sites for this trial call (919) 465-4648, Lodz
For additional information regarding sites for this trial call (919) 465-4648, Poznan
For additional information regarding sites for this trial call (919) 465-4648, Warsaw
For additional information regarding sites for this trial call (919) 465-4648, Madrid
For additional information regarding sites for this trial call (919) 465-4648, Navarre
Lead Sponsor
Aptevo Therapeutics
INDUSTRY